Topical Pain Relief Gel Market

Global Topical Pain Relief Gel Market Size, Share and Trends Analysis Report, By Type (Prescription Pain Relief Gel and Over-the-counter (OTC) Pain Relief Gel), By Distribution Channel (Pharmacies & Drug Stores, E-commerce and Retail & Grocery Stores), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025821 | Category : Pharmaceuticals | Delivery Format: /

The global topical pain relief gel market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Topical pain relief gels are rubbed in or applied onto the skin. It supports to relieve pain from muscles or joints. The major factor for the growth of the market is the Increasing prevalence of arthritis as well as other bone-related conditions along with diabetic neuropathy that leads to pain.

Moreover, the market is also growing due to the new product launches. For instance,  in January 2020, GlaxoSmithKline plc announced the launch of Iodex UltraGel. It is a clinically proven gel-based body pain solution that reduces internal swelling and gives 3X effective relief. Furthermore, in September 2017, Sanofi launched Combiflam Icyhot, an over-the-counter product. It is available in two formats, gel and sprays for instant and long-lasting relief to people suffering from muscle pains and sprains.

Some major players in the market include GlaxoSmithKline Plc (GSK), Johnson & Johnson, and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2020, GlaxoSmithKline announced the approval of Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as an over-the-counter (OTC) product from the US FDA for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults of 18 years and older.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Distribution Channel

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- GlaxoSmithKline Plc (GSK), Johnson & Johnson, and Novartis International AG, among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Topical Pain Relief Gel Market Report by Segment

By Type

    • Prescription Pain Relief Gel

    • Over-the-counter (OTC) Pain Relief Gel

By Distribution Channel

    • Pharmacies & Drug Stores

    • E-commerce

    • Retail & Grocery Stores

Global Topical Pain Relief Gel Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa